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Abstract
Exchange mechanisms across the blood–cerebrospinal fluid (CSF) barrier in the choroid plexuses within the cerebral
ventricles control access of molecules to the central nervous system, especially in early development when the brain is
poorly vascularised. However, little is known about their molecular or developmental characteristics. We examined the
transcriptome of lateral ventricular choroid plexus in embryonic day 15 (E15) and adult mice. Numerous genes identified in
the adult were expressed at similar levels at E15, indicating substantial plexus maturity early in development. Some genes
coding for key functions (intercellular/tight junctions, influx/efflux transporters) changed expression during development
and their expression patterns are discussed in the context of available physiological/permeability results in the developing
brain. Three genes: Secreted protein acidic and rich in cysteine (Sparc), Glycophorin A (Gypa) and C (Gypc), were identified as
those whose gene products are candidates to target plasma proteins to choroid plexus cells. These were investigated using
quantitative- and single-cell-PCR on plexus epithelial cells that were albumin- or total plasma protein-immunopositive.
Results showed a significant degree of concordance between plasma protein/albumin immunoreactivity and expression of
the putative transporters. Immunohistochemistry identified SPARC and GYPA in choroid plexus epithelial cells in the embryo
with a subcellular distribution that was consistent with transport of albumin from blood to cerebrospinal fluid. In adult
plexus this pattern of immunostaining was absent. We propose a model of the cellular mechanism in which SPARC and
GYPA, together with identified vesicle-associated membrane proteins (VAMPs) may act as receptors/transporters in
developmentally regulated transfer of plasma proteins at the blood–CSF interface.
Citation: Liddelow SA, Temple S, Møllga ˚rd K, Gehwolf R, Wagner A, et al. (2012) Molecular Characterisation of Transport Mechanisms at the Developing Mouse
Blood–CSF Interface: A Transcriptome Approach. PLoS ONE 7(3): e33554. doi:10.1371/journal.pone.0033554
Editor: Maria A. Deli, Biological Research Centre of the Hungarian Academy of Sciences, Hungary
Received November 8, 2011; Accepted February 12, 2012; Published March 21, 2012
Copyright:  2012 Liddelow et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The research leading to these results has received funding from the National Health and Medical Research Council (NHMRC, Australia) as part of an
agreement with the European Union Seventh Framework Program (FP7/2007–2013) under grant agreement No. HEALTH-F2-2009-241778. SL was funded by a
Company of Biologists Travelling Fellowship and an American-Australian Neurological Fellowship. SL, KD, HB, H-CB, RG, AW and NS are members of the Neurobid
Consortium, funded by the Seventh Framework Program (EU) and NHMRC. KM is an adviser to the Neurobid Consortium. The project was also supported by
funding from the Regenerative Research Foundation and Grant Number NS033529 from NIH/NINDS to ST. The funders had no role in the study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: shaneal@unimelb.edu.au
Introduction
The central nervous system functions in a well-controlled
environment and is protected by a set of mechanisms known
collectively as the blood–brain barrier [1]. These mechanisms are
present at five distinct interfaces: (i) the blood–brain barrier proper
at the level of the endothelium of the cerebral blood vessels; (ii) the
arachnoid barrier between the cerebrospinal fluid (CSF) in the
subarachnoid space and the dura; (iii) the pia/glia limitans
between the CSF in the subarachnoid space and extracellular fluid
of the brain, which is much more complex in the embryo; (iv) the
CSF-brain barrier, which is only a significant barrier in the
embryo, created by separation of the ventricular system from the
extracellular fluid of the brain by strap junctions in the
neuroependyma and (v) the blood–CSF barrier at the level of
the choroid plexus epithelial cells (Fig. 1). The importance of
these barriers in normal neural development and in pathological
conditions has been documented [2–5]. These same barrier
mechanisms protect the brain from the effects of toxins and
prevent the entry of many drugs [5,6].
Most studies of brain barrier properties have concentrated on
the cerebral endothelial cell interface (blood–brain barrier) with
much less work having been done on the choroid plexus interface
[7]. In the developing brain the differentiation and growth of the
choroid plexuses occurs much earlier than most of the vascular-
isation of the brain. Thus it has been suggested that in early
development the main portal of entry from blood into brain is via
the choroid plexuses and CSF rather than via the sparsely
distributed cerebral blood vessels [1,8].
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a morphological component in addition to cellular transport
mechanisms. The key morphological feature is the tight junctions
between the cells of the interfaces: cerebral endothelial cells at the
blood–brain barrier and epithelial cells at the choroid plexus
blood–CSF barrier [1,9]. The cellular transport mechanisms
encompass influx mechanisms for nutrients such as amino acids
and vitamins, and efflux mechanisms, which are important barrier
mechanisms that prevent the entry of many drugs and toxins into
the brain [5,10]. In addition, there are ion exchange mechanisms
and water channels that define the key features of the brain’s
internal environment which are essential for normal neuronal
function [8].
A key question for understanding brain development lies in
determining to what extent these barrier mechanisms are
functional in the embryonic and fetal brain and whether there
are barrier mechanisms that are specific to the developing brain.
In spite of numerous claims over nearly 100 years based on belief
and poor experimentation that embryonic brain barriers are
‘immature’, it is now clear that fundamental barrier properties are
present very early in development (see [1,9]). Daneman and
colleagues [2] have provided evidence of expression of numerous
blood–brain barrier genes in the developing brain, but there is no
equivalent information for the choroid plexuses.
An intriguing feature of CSF in the developing brain is its high
concentration of protein—which has been identified in all
mammalian species studied so far [11–15]. Experimental evidence
showed that most of these proteins in CSF originate from blood
plasma [15–18] although synthesis in situ in the choroid plexus also
contributes [19]. Previous studies suggest that a specific recogni-
tion mechanism for individual proteins is present at the blood–
CSF barrier, especially during early stages of brain development
[16–18,20,21] but the molecular identity of this mechanism
remains elusive. One molecule, secreted protein acidic and rich in
cysteine (SPARC), has been proposed to be involved in targeting
albumin to the blood-CSF interface—although it seems likely that
SPARC is not the only transporter involved [22].
In this study we have used Affymetrix GeneChip arrays to
describe the transcriptome of embryonic and adult mouse lateral
ventricular choroid plexus and mined these datasets for intercel-
lular junction and specific transporter genes. It is the first to
describe the lateral ventricular choroid plexus transcriptome in the
mouse embryo (at embryonic day 15) and to identify a set of genes
whose expression is enriched compared with the adult. A
transcriptome analysis of adult mouse choroid plexus has been
published previously [23]. We report that several genes coding for
proteins known to be albumin-targeting in other systems, are
expressed within a subset of epithelial cells of the choroid plexus
that are also immunopositive for albumin. We propose a way by
which this mechanism for protein transfer across choroid plexus
epithelial cells could operate.
Materials and Methods
Ethics statement
All animal experiments were conducted in accordance with the
Public Health Safety Policy on the Humane Care and Use of
Laboratory Animals (National Institutes of Health). All animal
research protocols were reviewed and approved by the State
University of New York – University at Albany Institutional
Animal Care and Use Committee and registered with the US
Office of Laboratory Animal Welfare (International Animal Care
and Use Committee Registration A3621-01).
Animal husbandry
Timed-pregnant and non-pregnant Swiss Webster female mice
supplied by Taconic Farms Inc. (NY, USA) were used in this
study. For general morphology and immunohistochemistry a
range of embryonic (E) and postnatal (P) ages were used: E12, E13,
E14, E15, E16, E19, P2, P15 and adult (10 weeks, 15–30 g). All
embryos were staged according to the guidelines of Theiler [24].
For general histology paraffin-embedded brain sections from all
ages were used (n=6 animals at each age). For Affymetrix
GeneChip arrays and qPCR validation lateral ventricular choroid
plexuses from E15 (n=100) and adult (n=30) were used. For
single-cell qPCR paraffin-embedded lateral ventricular choroid
plexus sections from E15 and adult were investigated (n=6 at each
age). These ages were chosen as they correlate to the time when
Figure 1. The choroid plexus and the blood–CSF barrier. A. The choroid plexuses are highly vascularised epithelial tissue that originates from
the neuroependyma in the developing brain (ependyma in adult) and float freely in each of the brain ventricles (the two lateral, third and fourth).
These specialised organs have two major functions: (i) to act as a diffusion barrier between the blood and the CSF; and (ii) they produce and secrete
the CSF that fills the ventricles and subarachnoid spaces. B. The choroid plexuses are comprised of a central stroma with many blood vessels covered
by a single layer of specialised epithelial cells, which rest on a thick basement membrane. C. The choroid plexuses are one of the circumventricular
organs (i.e. they are positioned at sites around the margin of the ventricular system of the brain) and, like blood vessels in this region of the brain, the
vessels of the choroid plexus stroma are fenestrated and the junctional strands linking adjacent endothelial cells are discontinuous. Accordingly,
molecules are able to leave the blood vessels and enter the basement membrane of the plexus (arrows). However, a protective barrier is present in
the choroid plexus, itself provided by tight, adherens, gap and other junctions between intimately apposed plexus epithelial cells – forming the
blood–CSF barrier. The presence of many junctions between adjacent plexus epithelial cells from its first appearance in development means that the
paracellular route for small molecules between blood and CSF is closed off in the embryo as well as in the adult. Abbreviations: BV, blood vessel; CP,
choroid plexus; CPEC, choroid plexus epithelial cell; CSF, cerebrospinal fluid; LV, lateral ventricle; St, stroma; TJ, tight junction; Scale bar: 500 mmi nA ,
25 mmi nB .
doi:10.1371/journal.pone.0033554.g001
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plasma protein-positive epithelial cells in the choroid plexus (see
below and Table S1).
Collection of brains for morphological studies
Embryonic animals were killed by decapitation, brains dissected
out under cold 4% PHEM fixative (1.23 M paraformaldehyde,
1.29 M PIPES, 0.55 M HEPES, 0.20 mM EGTA, 0.16 M
MgSO4) and post-fixed by immersion in Bouin’s solution (Sigma,
St Louis, MO, USA) for 24 hours. Postnatal animals were killed by
cervical dislocation and fixed by perfusion with cold 4% PHEM
fixative, for 10 minutes at 70% of cardiac output. Following
perfusion, brains were dissected out and post-fixed by immersion
in Bouin’s solution for 24 hours. Once fixed, all brains were
washed in 70% ethanol until clear, embedded in paraffin wax
(Sigma) and 5 mm coronal sections cut.
Collection of lateral ventricular choroid plexus
Animals were killed as above and brains dissected out under
cold RNase-free phosphate buffered saline (PBS, pH 7.3).
Cerebral hemispheres were separated and both lateral ventricular
choroid plexuses removed and placed in fresh ice-cold RNase-free
PBS. Plexuses were pooled from several litters, spun down, excess
PBS removed, snap-frozen in liquid nitrogen and stored at 280uC.
The choroid plexus consists of epithelium as well as blood vessels
and mesenchymal stroma. However, the epithelium is the
predominant cell type, suggested to represent up to 90% of the
plexus tissue [25]. In this study lateral ventricular choroid plexus
was taken in toto.
Microarray screen of lateral ventricular choroid plexus
Total RNA was extracted from pools of E15 and adult lateral
ventricular choroid plexus (from a minimum of 10 individuals in
each pool) using the RNeasy Mini Kit, Qiashredder columns and
gDNA removal columns according to standard supplier protocol
(Qiagen, Valencia, CA, USA). Approximately 2 mg of total RNA
from each of the six independent samples (three E15, three adult)
were processed and hybridised to a GeneChip Mouse Exon 1.0 ST
Array (Affymetrix, Santa Clara, CA, USA) using standard
procedures (www.affymetrix.com). Microarray hybridisation and
gel capture was performed by the Microarray Core Facility at the
University at Albany Centre for Functional Genomics (Rensselaer,
NY, USA). Array experiments were conducted according to the
Minimum Information About a Microarray Experiment (MIAME)
guidelines [26]. A checklist of these guidelines is provided in
Table S2. An excel spreadsheet of the full comparison dataset is
provided as Table S3 and the array data have been deposited into
the Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.
gov/geo/) with series accession number (GSE33009) and sample
accession numbers (GSM818292, GSM 818293, GSM818294,
GSM818295, GSM818926, GSM818927).
Affymetrix data analysis. For gene level analysis, the
Affymetrix Power Tools software (Affymetrix) was used to
normalise scanned images and to summarise the probe set.
Briefly, raw array data was RMA normalised (robust multichip
analysis, [27]) per chip median and filtered to include the top 80th
percentile of genes expressed. Following an un-paired t-test
(p,0.05), a Benjamini-Hochberg false discovery rate correction
[28,29] was applied before subjecting the list to a fold change cut-
off of two. Further, more stringent discrimination of target lists was
achieved using GoMiner
TM software (Application Build 253; [30]).
Targets were sorted using a combination of molecular and
biological gene ontology terms.
Real-Time qPCR validation
Total RNA was prepared from lateral ventricular choroid
plexus as outlined above. First-strand cDNA was synthesised using
a High Capacity RNA-cDNA conversion kit (Applied Biosystems,
Carlsbad, CA, USA). Real-time PCR was performed using SYBR
Green assay using the 7900HT Fast Real Time PCR System
running SDS2.3 software (Applied Biosystems). Gene expression
was determined relative to levels of expression of the transferrin
receptor using the DDCt method. Gene expression for transferrin
receptor has been shown not to change during plexus development
[31]. Standard deviations were calculated from triplicates of three
separate samples in each instance. Primers for target genes were
designed using the OligoPerfect
TM Designer (Invitrogen, Carls-
bad, CA, USA) and are listed in Table 1.
Laser capture and single cell PCR
Laser-capture microdissection was performed on paraffin-
embedded tissue sections of E15 and adult mouse lateral
ventricular choroid plexus. Randomly selected sections containing
lateral ventricular choroid plexus were immunostained with
antibodies to mouse albumin raised in goat (1:5000, abcam,
Cambridge, MA, USA, ab19194) or to mouse total plasma protein
raised in rabbit (1:5000, DAKO, Glostrup, Denmark, ZO177).
For a list and specification of antibodies refer to Table 2. After
washing with PBS+Tween20, sections were incubated with
appropriate secondary antibodies conjugated to peroxidase
(donkey anti-goat, 1:1000, Millipore/Chemicon, Vienna, Austria,
AP180P; goat anti-rabbit, 1:1000, Sigma, A-9196). Final visual-
isation was completed with the 3,39-diaminobenzidine reaction
(DAB Kit, DAKO). Laser microdissection of immunopositive or
immunonegative cells was performed with a Leica AS LMD
microscope (Leica, Vienna, Austria) and captured cells placed in
an RNase-free PCR cap. PCR was performed on single cells or on
Table 1. Primers (59R39) used for qPCR validation of targets
from array dataset.
Gene Forward Reverse
Gypa GCATGGGTGAAAGCGTTAGT GCCACAAAGCCTCTGAGTTC
Gypc CCCCTCAGCTGTGCTATCTC CCCTACAACATTCGGAGGAA
Sparc GAGGGCCTGGATCTTCTTTC CACGGTTTCCTCCTCCACTA
Vamp1 CTCCTCCCAACATGACCAGT ACTACCACGATGATGGCACA
Vamp5 CCAAGACTTTAGCCCAGCAG CTCGGAAGAAAGACGACCAG
Vamp8 CCTCCGAAACAAGACAGAGG ACAGGGACTGAGCAGCACTT
Tfrc TCGCTTATATTGGGCAGACC CCATGTTTTGACCAATGCTG
Abca2 CATCTTGTGTGGCAACAACC AAGCTTCGGATCTCTGTGGA
Abca4 AGGGAGAGCTGTGGTTCTCA AGCAAGTCGTCCTTTGGAGA
Abca5 GGACAAATTCAGCCTTTCCA GAAAGACTTGCGGCTACCAG
Abca7 GTTCTCTGGAGCTGGTTTCG CAGGGCTGAGACTGTTGTCA
Abcb2 CAGAGAACCTGGGAGCAAAG CACAACGCCACATAAACCAG
Abcb3 CCTGCCTTTCCTCATAGCTG CCTGTCTTGGTCTCCTGGAA
Abcb6 CTGGCTGACATCATCATTGG CGAAACTTGGCTCTCCACTC
Abcb9 GCGGTATTTTCACCCTCGTA GCGGTTCTCATCAAAGAAGC
Abcc1 (MRP) CCCAGTGGGAACCTAGTGAA CTGACTCCCAGCAAGGTCTC
Abcg2 (BCRP) TCACTGACCCTTCCATCCTC AATCCGCAGGGTTGTTGTAG
Abcg5 GTCCTGCTGAGGCGAGTAAC GCAGCATCTGCCACTTATGA
Abcg8 CCTCCGATTGCTTCTTTCAG GGCAATCAGAGTCAACAGCA
doi:10.1371/journal.pone.0033554.t001
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directly transcribed into cDNA using the High Capacity RNA-to-
cDNA master Mix (Applied Biosystems). PCR was performed
using the smallest available intron-spanning TaqMan Gene
Expression Assay (with amplicons ,100 bp, Applied Biosystems)
for Sparc (assay ID: Mm00470030_ml), Glycophorin A (Gypa, assay
ID: Mm00494848_ml) and Glycophorin C (Gypc, assay ID:
Mm00503602_ml). Amplification efficiency of the house-keeping
gene hypoxanthine-guanine phosphoribosyltransferase (Hprt, assay ID:
Mm01545399_ml) was used as an internal control. PCR products
were separated on an agarose gel and stained with ethidium
bromide.
Immunocytochemistry
Total protein and albumin staining – cell counting. Se-
lected 5 mm paraffin-embedded sections were dewaxed by heating
to 60uC and immersion in histolene, rehydrated through graded
alcohols and incubated with Peroxidase and Protein blocking agents
(DAKO) for 2 hours each in a moist chamber at room temperature.
After washing in PBS+Tween20, sections were incubated in an
antibody against mouse serum raised in rabbit (1:2000; DAKO,
Z0177) or against mouse albumin raised in goat (1:1000; abcam,
ab19194) overnight at 4uC. The following day, sections were
washed in PBS+Tween20 and incubated in appropriate secondary
antibody (see Table 2) for 2 hours. A final incubation in species-
specific peroxidase anti-peroxidase (1:200) for 2 hours at room
temperature was completed before antibodies were visualized with
DAB (DAKO) for 5 minutes. The reaction was halted distilled
water,beforesectionswere dehydrated throughgradedalcoholsand
mounted with Ultramount #4 mounting medium (Fronine,
Melbourne, VIC, Australia). Positive staining was recognised as a
brown colour. Negative control sections included those where the
primary antibody was omitted; these always appeared blank.
Antibody dilutions were made in PBS-Tween20 buffer with 0.2%
fish gelatine (Sigma).
Cell counting was performed on total plasma protein and
albumin stained sections. Data are provided in Table S1.
SPARC and Glycophorin A immunocytochemistry. In
some experiments sections were deparaffinised in xylene,
rehydrated through graded alcohols, treated with a 0.5%
solution of hydrogen peroxide in methanol for 15 minutes to
quench endogenous peroxidase and then rinsed in TRIS buffered
saline (TBS, 5 mM Tris-HCl, 146 mM NaCl, pH 7.6). Non-
specific binding was inhibited by incubation for 30 minutes with
blocking buffer (ChemMate antibody diluent S2022, DAKO) at
room temperature. The sections were then incubated overnight at
4uC with one of two rabbit polyclonal antibodies against human
SPARC (1:10000; abcam, ab14174; or 1:2500; Millipore/
Chemicon, AB1858, see Table 2) or a rabbit polyclonal
antibody against human GYPA (1:10000, abcam, #35032). The
two antibodies against SPARC gave similar appearances however
the abcam antibody gave better definition of the reaction product.
The sections were washed with TBS and incubated for 30 minutes
with a peroxidase-labelled polymer conjugated to goat anti-rabbit/
mouse immunoglobulins (EnVision
TM+ System/HRP K5007,
DAKO). The sections were washed with TBS, followed by
incubation for 6 minutes with DAB chromogen solution. Positive
staining was recognized as a brown colour. The sections were
counterstained with Mayer’s haematoxylin and dehydrated in
graded alcohols followed by xylene and coverslipped with DPX
Table 2. List and characterisation of antibodies.
Immunogen
Manufacturer
Species/Type
Catalogue Number
Dilution/
Application Characterisation Controls
Mouse albumin abcam
Goat/Polyclonal 1u
ab19194
1:1000/IHC Stains expected band of
Mr 69610
3 on Western blot
of whole mouse plasma.
Staining abolished after
pre-incubation with
purified mouse albumin.
Purified full length human
Glycophorin A protein
abcam
Rabbit/Polyclonal 1u
Ab35032
1:10000/IHC Stains expected band of Mr 40610
3
on Western blot of whole mouse
plasma and kidney tissue extract.
Staining abolished after
pre-absorption with
mouse plasma.
Recombinant full length
human SPARC protein
abcam
Rabbit/Polyclonal 1u
ab14174
1:10000/IHC - Staining abolished after
pre-absorption with
human plasma.
Recombinant SPARC expressed
in human embryonic kidney
line HEK-293
Chemicon (Millipore)
Rabbit/Polyclonal 1u
AB1858
1:100/IHC
1:2500/IHC
1:400/WB
Stains expected band of Mr 34610
3
on Western blot of whole mouse plasma
and kidney tissue extract (see Fig. 4D).
Staining abolished after
pre-absorption with
kidney tissue extract.
Purified immunoglobulin
fraction of rabbit antiserum
(total plasma protein)
DAKO
Rabbit/polyclonal 1u
Z0177
1:2000/IHC Reacts with mouse serum proteins
(crossed immunoelectrophoresis) – at
least 25 immunoprecipitates appear
after staining with Coomassie Brilliant
Blue (supplier bulletin).
Staining abolished after
pre-incubation with
mouse serum.
Immunoglobulins, mainly IgG,
isolated from rabbit serum
DAKO
Swine/polyclonal 2u
Z0196
1:200/IHC - -
Purified polyclonal IgG
prepared from pooled
mouse serum
DAKO
Rabbit/polyclonal 2u
Z0259
1:200/IHC - -
DAKO
Rabbit/polyclonal 2u
Z0228
1:200/IHC - -
Abbreviations: 1u, primary antibody; 2u, secondary antibody; IHC, immunohistochemistry; WB, western blot.
doi:10.1371/journal.pone.0033554.t002
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dilutions were made in blocking buffer (DAKO). Negative
control sections were prepared by omitting the primary antibody
and always appeared blank. Positive control sections were of
mouse kidney (supplier technical bulletin and [32,33] and were
always positive.
Western blot
To prepare samples for western blotting analysis, equal weights
of plexus tissue were defrosted on ice and mixed with 20 ml PBS
(with 0.2% Tween20) before disrupting with a glass mortar and
pestle. Tissue was then centrifuged (3 minutes at 900 g, 4uC) to
pellet excess cellular debris. Tissue homogenate (10 ml) was mixed
with 2.5 ml sample buffer (0.5 M Tris-HCl, 0.4 M glycerol, 0.2 M
b-mercaptoethanol, 10% w/v sodium dodecyl sulphate (SDS),
0.5% bromophenol blue, in distilled water). Samples were loaded
on 10% Tris-HCl polyacrylamide gels (BioRad, Gladesville, NSW,
Australia), with 4 ml of Kaleidoscope Molecular Weight Standard
(BioRad). Gels underwent electrophoresis at constant voltage
(100 V) in running buffer (25 mM Tris base, 192 mM glycine,
0.1% w/v SDS) for approximately 40 minutes, washed in cold
Towbin buffer (25 mM Tris base, 192 mM glycine, 20% w/v
methanol; [34]) and transferred at 200 V for 60 minutes to
polyvinylidene difluoride membranes (BioRad). Membranes were
blocked in a blocking solution of Towbin–Tween buffer (0.1 M
Tris, 1.5 M NaCl, 0.1% Tween 20) with 50% low-fat soy milk
overnight at 4uC. Membranes were probed using antibodies to
mouse SPARC (1:400, Millipore/Chemicon, AB1858) or anti-
bodies to mouse GYPA (1:500, abcam, ab20057), both raised in
rabbit. Antibodies were diluted in blocking solution (see above).
Incubation with primary antibody was for 2 hours at room
temperature. Following washing in Towbin–Tween buffer,
membranes were incubated with swine anti-rabbit immunoglob-
ulins (1:500, DAKO, Z0196) for 2 hours at room temperature.
Membranes were washed and incubated for a further 2 hours with
rabbit peroxidase anti-peroxidase (1:500, DAKO, Z0113). After
washing, specifically bound antibody was detected using DAB
tablets dissolved with urea (DAB Plus kit, Sigma). The reaction
was stopped in distilled water and membranes dried overnight
before being photographed. Kidney was chosen as a control tissue
as both SPARC and GYPA are known to be present in this organ
[32,35].
A list of all antibodies used in immunohistochemical, western
blot and single-cell PCR methods is provided in Table 2.
Statistical analysis
For statistical analysis InStat3 software (GraphPad, La Jolla,
CA, USA) was used to perform Student’s t-test and one-way
ANOVA (Dunnett or Tukey post-hoc test) as appropriate.
Results and Discussion
In order to identify different macromolecular transporters and
changes in gene expression at the blood–CSF barrier in mouse
development, Affymetrix GeneChip analysis was used to compare
gene expression in choroid plexus collected from embryo versus
adult mice. A previously described cell-counting method was used
to ascertain the number of total and protein positive epithelial cells
in the lateral ventricular choroid plexus of the mouse [18,21,36].
These data (provided in Table S1) were used to determine which
age had the highest percentage of plasma protein positive choroid
plexus epithelial cells to be compared with the adult in a
microarray screen, thus E15 was chosen for comparison with
adult. Lateral choroid plexus was chosen as this is the tissue on
which most of the previous data on protein transfer are available
[15,16,18,21].
Microarray results
In total, 23239 probe sets displayed positive hybridization to the
Affymetrix GeneChip. The relative gene expression in the plexus
is graphically represented by a dot plot (Fig. 2A), where each dot
represents a single probe set on the Affymetrix GeneChip, with the
X and Y logarithmic axis representing the two ages used in the
study. From this analysis the bulk of the genes expressed in the
lateral ventricular choroid plexus lies near the diagonal axis,
indicating that the expression levels do not differ between the two
Figure 2. Gene expression in lateral ventricular choroid plexus of E15 and adult mice. A. The data are presented in a dot plot on a
logarithmic scale, where each point represents a separate probe set on the GeneChip. Only probe sets that hybridized are represented, with no
absent probe sets present in the plot. Data presented in plot are representative of a single GeneChip experiment, however three biological replicates
were completed. Probe sets lying on the diagonal axis indicate similar levels of expression at E15 and adult. Validation using qPCR was completed on
a select number of targets (see Fig. 3 and 4). B. Pie chart of the percentage of gene ontology of 1803 genes with altered expression in mouse lateral
ventricular choroid plexus between the two ages. Protein binding, receptors and ATP binding genes accounted for 50% of all genes altered during
development.
doi:10.1371/journal.pone.0033554.g002
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included in further analysis, as the current study was focussed on
describing those genes with altered expression in development.
However, the large population of genes that did not significantly
change their expression indicates a high degree of developmental
maturity of the plexus even as early as E15 (three days after the
lateral ventricular plexus first begins to develop). The number of
probe sets that displayed changes in expression that were 2-fold or
higher was 1805, of which 925 were enriched at E15 and 880 were
enriched in the adult (see Table S3). The top 50 enriched genes
are listed in Table 3. More stringent discrimination was applied
to the gene list using GoMiner
TM software (Application Build 253;
[30]). Criteria were applied to identify gene targets according to
their biological process, molecular function (transporter activity,
receptor or vesicle-mediated transport, ion channel, ATPase,
ATP-binding) or cellular component (tight junction, plasma
membrane). We have previously suggested the presence of putative
plasma protein-binding molecules at the blood–CSF barrier
[17,20,22], therefore additional classification using molecular
function (protein binding) was also carried out. Following
classification into these broad biologically coherent categories,
several classes of genes with altered expression in development
were identified: cell adhesion (118 targets, Table S4), ion
transport (101 targets, Table S5), solute carriers (56 targets,
Table S6), efflux transporters (181, Table S7) and the largest
group - protein binding (480 targets, Table S8, see also Fig. 2B).
The relevant functional data sets are available as Tables S4, S5,
S6, S7, S8. This report will concentrate on genes known to be
associated with brain barrier function: tight junction and cell
adhesion molecules, ion and water channels, efflux and influx
transporters (especially potential protein transporters).
Cell adhesion and tight junction genes
Tight junctions form the structural basis of the blood–brain and
blood–CSF barriers [9,37]. The physiological function of tight
junction complexes in restricting paracellular diffusion between
blood and the CSF is present very early in development [38,39].
Key ultrastructural components such as the number and
complexity of protein strands that make up the junction have
been shown not to change significantly between very early
gestation and adult [40]. Many of the typical proteins found in
tight junctions such as ZO-1, occludin and claudins 1, 3–18 and 23
were present in the GeneChip array screen of mouse lateral
ventricular choroid plexus. Their expression was similar at E15
and adult (Table 4 and Table S4). Cldn2 (Claudin 2) and several
junctional transmembrane molecules, cytoplasmic adaptors and
regulatory small GTPase transcripts did show an age-dependent
enrichment in the lateral ventricular choroid plexus (Table 4). In
particular, Cldn2 was up-regulated 4-fold in the adult plexus. In
contrast, in the embryo, the junctional adhesion molecule Jam3,
proposed to be an integral part of tight junction complexes,
displayed a 3-fold higher expression. The higher expression of
Jam3 in the developing plexus is important as this protein has been
implicated in the establishment of the earliest cell-to-cell contacts
that even precede tight junction formation [41]. The Racgap1 (Rac
GTPase activating protein 1), also important for the establishment
of junctions, was enriched 16-fold at E15. Rac-1, in general, is a
major regulator of barrier function and its activation is important
for tight junction formation, which along with activation by Tiam1
controls tight junction biogenesis by binding to and activating the
Par polarity complex [42]. Additionally, Cdh2 (cadherin-2/N-
cadherin) and Cdh11 (cadherin-11), both up-regulated in the
embryonic choroid plexus (Table 4) appear to be important in
delineating compartments in the embryonic brain [43,44] but
have not previously been identified in the choroid plexus. Pcdh18
(protocadherin-18, 6.8-fold increased expression in the embryo) is
involved not only in cellular migration during development, but
also in cell adhesion [45].
In the adult Igsf5 (immunoglobulin superfamily 5/Jam4) was up-
regulated nearly 10-fold (Table 4). The function of this adhesion
molecule is dependent on simultaneous expression with other
proteins such as Occludin, ZO-1 and Magi1 (membrane
associated guanylate kinase with inverted domain structure-1)
and were identified in the array screen but displayed no
enrichment at either age. Occludin, Marveld2 (tricellulin) and
Marveld3 are involved in stabilisation of tight junctions; transcripts
for all 3 were detected, but only Marveld3 was differentially
regulated (up 4.2-fold in the adult plexus). Although important for
the stabilisation of tight junctions, lower expression of Marveld3 is
reported not to disturb junction formation but does increase the
trans-epithelial electrical resistance in cultures of epithelial cell
lines [46], suggesting that Marveld3 may also be important for
mediating paracellular ion permeability.
Genes coding for other intracellular accessory tight junctional
proteins such as Dlgh1/5, Mpp1/5/6/7, and Mpdz were present in
the embryo and showed no change in expression level compared
to adult. These intracellular proteins are important components of
the tight junction complex structure for two reasons: firstly they
anchor the junction to the cytoskeleton; and secondly they may
help to regulate the overall function of the structure [38]. Though
these molecules are important for junction integrity they are not
definitive for the barriers of the brain, but are more broadly
components of tight junctions throughout the body [38]. The
specific brain barrier accessory proteins Pard3 and Cingulin-like 1
(jacop) described by Daneman et al. [2] were unchanged in the
lateral ventricular choroid plexus in development. This expression
of these tight junction–specific molecules at E15 supports the
previously described physiological and EM studies demonstrating
functional maturity of the blood–CSF barrier even in very early
developing brain [39].
The kinesin family member protein, Kif11, essential for moving
vesicles and organelles within cells along microtubules, was
increased 8-fold in the embryo compared to the adult, which
could point to a greater importance of these intracellular transport
mechanisms in the embryo. Other family members, Kif2c
(important for removal of tubulin dimers from microtubules),
Kif20a, Kif22 and Kif23 were all up-regulated in the embryo, 7.3-,
5.5-, 4.0- and 4.0-fold respectively. Both Kif11 and Kif2c are highly
ATP-dependent, in line with the highly metabolically active nature
of these cells. These genes may be important in mechanisms that
involve vesicular transport (see below).
Ion transporters and channels
A key component of the internal environment of both the adult
and developing brain is the stability of the ionic composition of the
CSF, which is usually assumed to reflect that of brain interstitial
fluid. The ionic composition of CSF in developing brain is
different from the adult. Some CSF/plasma gradients are
established very early in development, indicating the integrity of
tight junctions is already restricting paracellular pathway diffusion
of ions and that there are active ion pumps in the plexus epithelial
cells (see [9] for summary). In the adult, the key mechanisms
involved in CSF secretion are carbonic anhydrase, which
generates HCO3
2 that is transported across the epithelial cells
and the sodium-potassium exchanger (Na+/K+ ATPase) in the
apical membrane of the plexus epithelial cells [47]. In fetal rat
choroid plexus the levels of carbonic anhydrase and Na+/
K+ATPase are known to be much less than in the adult [8].
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(A) Gene GenBank ID Fold Change (B) Gene GenBank ID Fold Change
H19 BC025150 81.0 Prlr BC096586 234.3
Slc16a10 BC052877 66.8 Agxt2 M22959 97.1
Gpc3 BC036126 60.4 Cox8b BC086930 28.8
Ddx3y BC021453 24.1 Kl AB005141 27.4
Rspo2 NM_172815 19.3 D12Ertd647e BC128276 25.3
Hist1h1b NM_020034 17.6 Scd1 BC007474 24.1
Ccna2 BC052730 17.1 Tgfb2 BC011170 18.5
Igf2bp1 BC051679 16.6 Hist1h2bc BC019673 18.3
Racgap1 AB030252 16.0 Maob BC113788 17.9
Sulf2 AK129316 15.9 Inmt BC013518 17.8
Abcg5 AF312713 14.1 Cpxm2 AF017639 16.4
Ccdc67 BC096547 13.1 Npal2 BC030399 15.5
4930579J09Rik AY032666 12.8 Sod3 U38261 14.8
Ppic M74227 12.1 Sult1c2 AY005469 14.5
Slc6a15 AY149280 11.4 Ltc4s U27195 14.2
Bex1 BC058805 11.3 Slc5a5 AF235001 13.6
Tpx2 BC060619 11.2 Tmem184a BC026659 13.3
Fscn1 BC052408 11.1 Ppp2r2c BC059811 13.1
Nrk AB020741 10.7 Sytl2 AB057754 12.3
Rassf4 BC060709 10.6 F5 U52925 11.7
Prom1 AF039663 10.6 Sfrp5 BC032921 11.7
Tmem26 BC117502 10.3 BC055107 BC055107 11.1
Prc1 BC059808 10.0 Steap1 BC061023 10.8
Asb4 BC046819 9.7 Chdh BC039186 10.8
Slc40a1 AF231120 9.6 Il1r1 M20658 10.2
Wfikkn AY308804 9.6 Acsl6 AY786360 10.2
Rspo3 AB055811 9.4 Pla2g5 AF162713 10.2
Cdc2a U58633 9.2 Ccl9 U15209 10.2
Gli3 NM_008130 9.1 Plek2 AF170564 10.1
Gdf5 U08337 9.0 Abca4 AF000149 9.7
Col3a1 BC043089 8.8 Rdh5 AF033196 9.7
Fn1 BC051082 8.7 Scx BC062161 9.6
Plk1 L19558 8.6 Slc39a4 BC023498 9.6
Crabp2 M35523 8.6 Klf9 Y14296 9.6
Pbk BC020099 8.5 Rrh BC046288 9.6
Bub1b AF107296 8.4 Igsf5 BC004806 9.6
Kif11 BC060670 8.2 Lrrtm2 AY182027 9.4
Kit BC052457 8.1 Ppp1r1b BC011122 9.3
Fstl1 M91380 7.9 Crhr2 U19939 9.0
A230106N23Rik BC116972 7.9 Cd74 BC096435 9.0
Calcrl AB015595 7.8 Nos1 D14552 8.9
Ccnb2 BC008247 7.7 Kcnh1 U04294 8.9
Sema6a BC059238 7.7 Bdkrb1 BC120684 8.8
Pnck AF181984 7.7 Car5b AF192978 8.7
Ctnna2 BC079648 7.6 Gabrb1 BC130258 8.6
Col4a1 J04694 7.5 Slc41a2 NM_177388 8.5
Mfap2 L23769 7.5 Gpr37l1 AB016602 8.5
Cercam D16263 7.5 Me3 BC099935 8.4
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Thus the alpha subunit of the Na+/K+ATPase (atp1a2) was up-
regulated in the adult over 7-fold: similarly, the carbonic
anhydrases (CA5b, CA8, CA13) were up-regulated 4- to 9-fold in
the adult (Table S3).
In the adult there was also enrichment in potassium ion
channels (Kcnh1, Kcnd3, Kcnd3, Kcnh2 and Kcnk1) ranging from 3 to
8-fold of levels seen at E15 (Table 5), while very few potassium-
only ion channels showed increased expression in the embryo
(though Trpm5, a potassium, sodium, caesium and calcium ion
channel was 6.9 fold enriched, Table 5). The major extracellular
cation, sodium, is transported by a number of solute carrier (Slc)
gene products. Some were enriched in the embryo (Slc6a13 – 4.6-
fold, Slc4a4 – 4.1-fold) and others in the adult (e.g. Slc5a5 – 13.6-
fold; Slc24a4 – 7.8-fold, Table 5 and Table S5). Anion
transporters are also fundamental components for maintenance
of the internal environment of the brain as well as CSF secretion,
in particular Cl
2 and HCO3
2. Anion transporters known to be
important in adult choroid plexus belong to the Slc4 family
[46,47]. Two that were up-regulated in the embryonic choroid
plexus are Slc4a1 (Cl
2-HCO3 exchanger) and Slc4a4 (Na
+-HCO3
2
co-transporter) see Table 6. No functional studies on individual
ion transporters in developing brain or choroid plexus have been
published, but it is possible to infer ion transport function from
studies of CSF and plasma ion composition in the developing
brain. Ion gradients between CSF and plasma are a characteristic
of brain homeostasis [48]. Some ion gradients are established very
early in brain development, for example Cl
2 in fetal sheep [49]
and neonatal rats [50]. This indicates that ion transport
mechanisms are functional early in brain development, indicating
functional activity of the ion transporters expressed in developing
choroid plexus.
Aquaporins
Aquaporins 1–9, 11, 12 were all expressed at similar levels in
both embryonic and adult choroid plexus epithelial cells (Table
S2). Only Aquaporin 1 has been established as having a clear
function in water transport and CSF secretion in the choroid
plexus [45]; it has previously been shown that this water channel is
demonstrable immunohistochemically as soon as the choroid
plexus differentiates and the expression level, as determined by
real time RT-PCR did not change between E14 and adulthood
[51].
Amino acid influx transporters
Numerous members of the solute carrier gene family (Slc)o f
membrane transport proteins were present in the choroid plexus
(Table 5, Table 6 and Table S6). This large family (with over
300 members) is involved in the transport of many solutes across
cellular membranes, and include ion channels and aquaporins (see
above) facilitative transporters and active transporters. Three
categories of expression of solute carriers were found in the
developing mouse choroid plexus: those enriched in the embryo,
those enriched in the adult, and those with relatively high
expression levels that did not change with development. At E15,
the mouse lateral ventricular choroid plexus contained many
carriers involved in the transport of amino acids: Slc16a10 (67-fold
increase), Scl7a11 (7-fold) and Slc1a4, Slc38a4 and Slc7a1 (all
approximately 4-fold). These are summarised in Table 6. The
transport of amino acids into the CSF and the developing brain is
important for normal development. Most are directly involved in
protein metabolism underlying cellular growth of the brain. Some
are important because they act as carriers, for example, thyroid
hormone transporters. The main ones so far described, Slc16a2
(MCT8) and Slco1c1 (Oatp14), have recently been identified in
cerebral endothelial and choroid plexus epithelial cells of rat
fetuses [52]. In the present study the expression levels of these
transports were similar in E15 and adult choroid plexus, as were
many other transporters in the MCT and Oatp families (Table
S3). Another thyroid hormone transporter Slc16a10 (TAT1,
MCT10; [52]) showed strikingly high expression in embryonic
Table 3. Cont.
(A) Gene GenBank ID Fold Change (B) Gene GenBank ID Fold Change
Casp7 D16263 7.5 Sult4a1 BC054757 8.4
Vcan BC115766 7.4 Aox1 AB017482 8.4
The top 50 most enriched lateral ventricular choroid plexus-specific gene targets in the embryo (A) or adult (B). Fold change column represents the increases in the
number of transcripts for each gene compared to levels in opposing age (eg. a fold change of 3.0 for an embryonically enriched gene has expression 3-times higher
than the adult). For full data set, refer to Table S3.
doi:10.1371/journal.pone.0033554.t003
Table 4. Tight junction and associated proteins enriched in
mouse lateral ventricular choroid plexus.
(A)
Gene
GenBank
ID
Fold
Change
(B)
Gene
GenBank
ID
Fold
Change
Transmembrane
Pcdh18 BC052198 6.9 Igsf5 BC004806 9.6
Cdh5 BC054790 4.3 Cldn2 BC085494 4.3
Cmtm3 AY241870 4.0 Marveld3 BC025851 4.2
Cdh2 AB008811 3.4 Cldn12 BC024057 2.1
Jam3 BC024357 3.2
Cldn11 BC021659 2.0
Cytoplasmic Adaptors
Asb4 BC046819 9.7 Ankrd57 NM_172939 4.9
Ctnna2 BC079648 7.6 Ank DQ832285 3.3
Lama4 U59865 6.7 Lin52 BC048485 3.2
Arhgap11 AK129034 5.7 Prkcz BC072590 3.0
Dlg7 AB076696 5.5
Cdh11 BC046314 3.7
Regulatory Adaptors
Racgap1 AB030252 16.0
Rhobtb3 AK129234 4.6
List of proteins known to be associated with tight junctions that were up-
regulated in either the embryo (A) or the adult (B) expressed as fold change
compared to levels in other age. A full list of gene products involved in cell
adhesion can be found in Table S4.
doi:10.1371/journal.pone.0033554.t004
Transcriptome Analysis of Choroid Plexus Transport
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33554choroid plexus (Table 6). However, Slc16a10 has been previously
reported as undetectable in the adult brain [53]. TAT1 (Slc16a10,
MCT10) has also been proposed to be involved in endocytotic
membrane sorting and recycling [54]; its expression in developing
choroid plexus may be relevant to the protein transport
mechanisms discussed below.
Direct measurement of amino acid transport in the brains of
newborn animals has previously shown that many amino acids are
indeed transported to a higher degree than in the adult [55–58].
This was supported by the finding in our study of enrichment of a
large number of amino acid transporters at E15 (Table 6). In
contrast, in the adult only one solute carrier responsible for the
movement of amino acids was up-regulated (Slc6a17), although
many more were actually present, either in levels not differing
from the embryo, or less than at E15. Table 6 indicates the
available information on function of these transporter mechanisms
in the developing brain; it is not yet possible to link directly the
expression and transport function of individual genes in the
developing brain. This is partly because many of the genes have
only been identified recently, but also because of redundancy, the
current experimental evidence is not adequate to define the
function of individual genes. These earlier results from studies of
amino acid transport are consistent with our overall finding of a
higher level of expression of a large number of Slc genes in the
embryonic choroid plexus compared to the adult.
Efflux transporters
The ATP-binding cassette (ABC) transporter family has been
shown to be a key element of both the blood–brain and blood–
CSF barriers from very early in development that can actively
efflux a large number of lipophilic drugs [59]. ABC transporters
are divided into seven distinct subfamilies: ABC1, multidrug
resistance proteins (MDR/TAP), multidrug resistance-associated
proteins (MRP), ALD, OABP, GCN20 and White. While many of
these could be detected in the present screen of choroid plexus,
most did not show evidence of developmental regulation (Table 7
and Table S7). Two efflux transporters, Abcg5 and Abcg8, were
up-regulated 14.1- and 3.7-fold respectively at E15 compared to
the adult. These have both been detected previously in adult rat
Table 5. Influx transporters and ion channels enriched in
mouse lateral ventricular choroid plexus.
(A)
Gene
GenBank
ID
Fold
Change
(B)
Gene
GenBank
ID
Fold
Change
Solute Carriers
Slc16a10 BC052877 66.8 Slc5a5 AF235001 13.6
Slc6a15 AY149280 11.4 Slc39a4 BC023498 9.6
Slc40a1 AF231120 9.6 Slc41a2 NM_177388 8.5
Slc7a11 AY766236 7.1 Slc24a4 AY156046 7.8
Slc4a1 BC053429 5.5 Slc28a3 BC013783 6.9
Slc6a13 BC029637 4.6 Slc24a5 AB085629 6.1
Slc1a4 BC043483 4.4 Slc9a7 BC058750 5.8
Slc38a4 AY027919 4.2 Slc6a17 AY155578 3.5
Slc6a6 L03292 4.1 Slco1c1 AY007379 5.2
Slc4a4 AF141934 4.1 Slc4a10 AK220501 5.0
Slc7a1 M26687 4.1 Slc39a14 AB177995 4.0
Slc39a8 BC006731 3.3 Slc35f3 BC115965 3.9
Slc13a4 BC089161 3.9
Slc37a2 AF121081 3.5
Slco1a5 AF240694 3.4
Slc39a12 BC089362 3.3
Slc46a1 BC057976 3.2
Slc25a35 BC019996 3.1
Slc22a5 AF110417 3.0
Ion Channels
Racgap1 AB030252 16.0 Steap1 BC061023 10.8
Trpm5 AB039952 6.9 Kcnh1 U04294 8.9
Myb M12848 6.5 Gabrb1 BC130258 8.6
Kcnip1 AY171234 5.3 Gabra4 BC094603 7.9
Gabrg BC099939 3.8 Atp1a2 BC036127 7.7
Cngb3 AJ243572 3.7 Trpv4 AF279672 7.6
Ttyh3 BC062917 3.6 Chrnb4 AF492840 6.9
Gabra3 M86568 3.4 Nwd1 BC024788 6.3
Fxyd6 BC051127 3.3 Cacnb4 BC026479 6.4
Slc9a7 BC058750 5.8
Atp2a3 BC026147 5.7
Atp13a4 BC048410 5.6
Dmpk BC075715 5.4
Kcnd3 AF107781 5.4
Trf BC092046 5.1
Pln BC061097 4.7
Best3 AY450426 3.7
Kcnh2 AF012868 3.5
Atp1b1 BC094070 3.3
Kcnk1 AF033017 3.2
Solute carriers and ion channels up-regulated in either the embryo (A)o rt h e
adult (B). In total, 157 targets were found for these gene ontology categories,
with only those targets with fold change .3.0 shown above. A comprehensive
list is presented in Table S5, S6.
doi:10.1371/journal.pone.0033554.t005
Table 6. Expression and function of transporters in
developing choroid plexus.
Transporter Fold Change Transport Function Reference
Slc16a10 66.8 iodothyronines T3, T4 [92]
Slc6a15 11.4 neutral amino acids [57]
* Slc40a1 9.6 iron [93]
Slc7a11 7.1 cysteine, glutamate [57]
Slc4a1 5.5 anion transporter,
(Cl
2-HCO3 exchange)
[46,49]
Slc6a13 4.6 GABA transporter [94]
Slc1a4 4.4 glutamate, neutral amino acids [95]
Slc38a4 4.2 acidic & neutral amino acids [57,95]
Slc6a6 4.1 taurine [57]
Slc4a4 4.1 Na
+-HCO3
2 cotransporter [46]
Slc7a1 4.1 acidic amino acids [57]
Slc39a8 3.3 zinc transporter [96]
The expression levels for the transporters listed were obtained from Affymetrix
array analysis of E15 and adult mouse choroid plexus. Only Slc4a4, Slc7a11 and
Slc40a1 have previously been identified in choroid plexus. Fold change in
expression compares E15 to adult choroid plexus. Superscript numbers indicate
published studies showing transport into developing brain or CSF.
*Gene product ferroportin-1 identified in choroid plexus.
doi:10.1371/journal.pone.0033554.t006
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transporter genes have been shown to be differentially expressed in
developing rat choroid plexus [10]. We found that BCRP (Abcg2)
showed a strikingly higher expression in embryonic rat choroid
plexus, whereas PGP (Abcb1) was not significantly different and
MRP1 (Abcc1) and MRP4 (Abcc4) expression was significantly less
in the embryo [10]. In the present study some of these genes were
validated in mouse choroid plexus using RT-PCR (Fig. 3,
Table 6). This confirmed that Abcg2 (BCRP), Abcg5 and Abcg8
were substantially up-regulated in the embryonic choroid plexus as
were Abcb3 and Abcb6 (Fig. 3A). In the adult Abca2 and Abca4
were up-regulated compared to E15 choroid plexus (Fig. 3B). The
higher expression of BCRP (Abcg2) in the embryonic choroid
plexus may be related to the physiologically hypoxic environment
in utero [60] as it has been reported that hypoxia causes up-
regulation of BCRP [61]. However, these latter findings need to be
interpreted with caution, because of the in vitro conditions in which
the experiments were conducted (see [6]).
Protein binding
The protein concentration in CSF in the developing brain is
higher than in the adult (for review see [14]). It has been suggested
that a protein-specific transfer mechanism may regulate move-
ment of some proteins from blood into CSF and that this
mechanism could be receptor-mediated [16,17,18,20–22]. The
physiological importance of high protein concentration in the
developing CSF has been proposed to be: (i) maintaining high
colloid-osmotic pressure gradients allowing normal brain devel-
opment; and, (ii) act as a carrier for many essential molecules such
as growth factors, hormones or nutrients (for review see [8]). The
array dataset obtained in this study was mined for candidate genes
with known protein-binding properties. The results are shown in
Table 8 and Tables S2 and S8. Three of the targets identified,
Gypa, Gypc and Sparc (osteonectin/BM-40/culture-shock protein)
were selected for further study because of their reported role in the
binding of albumin [62]. SPARC has also been recently reported
in the choroid plexus epithelium [22].
Glycophorins are the main sialoglycoproteins of erythrocytes
(for review see [63,64]). Although there is evidence that many
plasma proteins seem to be transferred from blood into the CSF,
albumin has been most extensively studied [9,15,17,20,22]. GYPA
and other albumin-binding proteins which are able to facilitate the
transcytosis of native albumin in peripheral vascular beds and
epithelial tissues have been reported to be virtually absent in adult
brain capillaries [62]. Another albumin binding protein, SPARC
(osteonectin/BM-40/culture-shock protein), is a soluble protein
that can be found either incorporated into the plasma membrane
of cells, floating free in the cytoplasm of cells or extracellularly in
Table 7. ABC transport/drug efflux gene expression in mouse lateral ventricular choroid plexus.
(A) Gene Other IDs array qPCR (B) Gene Other IDs array qPCR
Abcb3 TAP2 - 16.5 Abca2 3.5 22.4
Abcb6 UMAT,MTABC3 2.6 8.1 Abca4 ABCR,RP19,RIM 9.7 12.9
Abcg2 BCRP - 15.8 Abca5 2.5 1.4
Abcg5 Sterolin1,White3 14.1 44.8 Abca7 ABCX 4.5 -
Abcg8 Sterolin2,White4 3.4 20.3 Abcb9 TAPL 2.8 1.8
Abcc1 MRP,MRP1 2.3 -
(C) Gene Other IDs array (C) Gene Other IDs array
Abca1 TGD, CERP NC Abcc3 MRP3 NC
Abca3 ABC-C NC Abcc5 ARP5 NC
Abca6 NC Abcc6 MRP6 NC
Abca8a NC Abcc9 SUR2 NC
Abca8b NC Abcc10 MRP7 NC
Abca9 NC Abcc12 NC
Abca12 NC Abcd1 ALD,ALDP NC
Abca13 NC Abcd2 ALDL1,ALDR NC
Abca14 NC Abcd3 PXMP1,PMP70 NC
Abca15 NC Abcd4 PXMP1L,P70R NC
Abca16 NC Abce1 OABP NC
Abcb1a MRD1, P-GP NC Abcf1 NC
Abcb2 TAP1 NC Abcf2 NC
Abcb4 MDR3 NC Abcf3 NC
Abcb8 M-ABC1 NC Abcg1 White NC
Abcb10 M-ABC2,MTABC2 NC Abcg3 NC
Abcb11 BSEP,SPGP,PGY4 NC Abcg4 White4 NC
Abcc2 MRP2 NC
Most enriched genes during development of the mouse lateral ventricular choroid plexus in the embryo (A) or adult (B). Some genes were present at both ages with no
alteration in expression levels (C). Data obtained from Affymetrix GeneChip array and qPCR. Array targets were considered enriched with fold changes equal or greater
than 2.0. See also Table S7. Abbreviations: NC, no change (in expression); -, not tested.
doi:10.1371/journal.pone.0033554.t007
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shown to be involved in protein binding (especially of albumin) in
other epithelia [32,35]. It has also been proposed to be a targeting
molecule for albumin at the blood–CSF barrier [22] and to
modulate cell matrix interactions, inhibit proliferation and affect
growth factor signalling, as well as bind calcium and proteins such
as albumin [66–71]. SPARC has been found localised to the
basement membrane of many cell types [66]. Further analysis was
restricted to targets related to protein transport properties of the
choroid plexus.
Both Gypa and Gypc along with Sparc were found to be enriched
in the lateral ventricular choroid plexus at E15 compared with the
adult (6.1-, 3.7- and 2.2-fold respectively). These changes were
confirmed with qPCR (Fig. 4C). Antibodies to SPARC and
GYPA were used in western blots to estimate the change in levels
of the protein present in developing choroid plexus cells. These
results are presented in Fig. 4D and show that there were higher
levels in the embryo than in the adult.
Single cell PCR. To ascertain the cellular co-localisation of
albumin and its putative targeting proteins Sparc, Gypa and Gypc,
laser dissection of both albumin- and total plasma protein-
immunopositive plexus epithelial cells followed by single-cell
RT-PCR was performed. The data are shown in Fig. 4E. For
immunostained cells, 60–80% of albumin-immunopositive plexus
epithelial cells showed expression of Sparc and both glycophorins at
E15. For glycophorin targets this increased to 90–100% in the
adult. In contrast, Sparc-expression in the adult was only present in
approximately 40% of albumin-immunopositive plexus cells.
Albumin- and total plasma protein-immunonegative cells of the
plexus epithelium did not show amplification signals for either
Sparc or the glycophorins at any age (Fig. 4E). In embryonic
choroid plexus, numbers of cells immunopositive for total plasma
protein that also showed high Sparc expression were higher than
those immunopositive for albumin. All of the total plasma protein-
immunopositive cells were also positive for both Gypa and Gypc.I n
the adult choroid plexus, the number of total plasma protein-
immunopositive cells that were also Sparc-positive was less than in
the embryo. All plasma protein immunostained cells were positive
for Gypa, but for Gypc fewer plasma protein-immunopositive cells
were positive than was the case for embryonic choroid plexus. The
generally higher proportion of cells immunostained for total
plasma protein than for albumin that also expressed these putative
transporters indicates that SPARC and GYPA and GYPC are
likely to be involved in transport of other plasma proteins, in
addition to albumin, across choroid plexus epithelial cells.
Cellular & subcellular distribution of Glycophorin A. In
order to investigate the possible role of one of these albumin-
binding molecules in transport across the blood–CSF barrier, we
have examined the distribution of GYPA at the cellular and
subcellular level in lateral ventricular choroid plexus throughout
mouse development from E12 onwards (see Methods) using a
cross-reacting polyclonal antibody and the EnVision
TM+ system.
Results are illustrated in Fig. 5. GYPA was detected in individual
choroid plexus epithelial cells of animals at all ages from the first
appearance of the lateral plexus at E13 (not shown), with a peak in
intensity at E15–E16. Most epithelial cells exhibited weak
immunoreactivity at this age but there were some cells,
particularly in the older parts of the plexus (upper part of
Fig. 5A), that showed strong immunoreactivity on the apical
(CSF) surface (Fig. 5A). There was a marked decrease in
immunoreactivity in the adult (Fig. 5B). The staining pattern
was also different at different developmental ages. At E15 choroid
plexus epithelial cells exhibited a predominantly peripheral plasma
membrane-associated staining in both epithelial (apical and
basolateral cell membrane) and endothelial cells (Fig. 5A). In
contrast, in adult choroid plexus, immunoreactivity in general was
absent from both apical and basolateral choroid plexus epithelial
cell membranes, but was present intracellularly at a low level. In a
few small segments of the plexus a stronger positive intracellular
staining for GYPA was present (framed area in Fig. 5B).
At the subcellular level at the youngest ages, E13 and E14, a
strong fine granular immunoreactivity for GYPA was present in
Figure 3. qPCR validation of microarray gene targets. Several
members of the ABC family of efflux transporters were up-regulated in
the embryo (A) and in the adult (B). The direction of these changes was
in line with what was found using the Affymetrix GeneChip platform,
though the magnitude of the expression was different. C. Three
members of the vesicle-associated membrane protein (Vamp) family of
proteins were down-regulated in the embryo (up-regulated in the
adult).
doi:10.1371/journal.pone.0033554.g003
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cells opposite the hippocampal anlage. This segment of the plexus
showed a weak staining of the epithelial basal membranes and of
endothelial cell surfaces (not shown). The most intense staining
was visible at E15 when pronounced membrane-associated GYPA
immunoreactivity was visible along the apical surface of epithelial
cells of larger segments of plexus (Fig. 5A). In the same areas
basolateral membranes as well as endothelial cell membranes were
also strongly stained (Fig. 5A). A few small vesicles in the apical
cytoplasm showed reactivity whereas the nuclei were always
Table 8. Protein binding targets enriched in mouse lateral ventricular choroid plexus.
(A) Gene GenBank ID Fold Change (B) Gene GenBank ID Fold Change
Hist1h1b NM_020034 17.6 Kl AB005141 27.4
Ccna2 BC052730 17.1 Tgfb2 BC011170 18.5
Bex1 BC058805 11.3 Cpxm2 AF017639 16.4
Fscn1 BC052408 11.1 Sod3 U38261 14.8
Rassf4 BC060709 10.6 Sytl2 AB057754 12.3
Wfikkn2 AY308804 9.6 Sfrp5 BC032921 11.7
Cdc2a U58633 9.2 Il1r1 M20658 10.2
Gli3 NR_027010 9.1 Acsl6 AY786360 10.2
Gdf5 U08337 9.0 Igsf5 BC004806 9.6
Fn1 BC051082 8.7 Lrrtm2 AY182027 9.4
Plk1 L19558 8.6 Crhr2 U19939 9.0
Pbk BC020099 8.5 Cd74 BC096435 9.0
Kit BC052457 8.1 Nos1 D14552 8.9
Sema6a BC059238 7.7 Gabrb1 BC130258 8.6
Ctnna2 BC079648 7.6 Atp1a2 BC036127 7.7
Cercam NM_207298 7.5 Trpv4 AF279672 7.6
Cntn4 BC115766 7.4 Rnf152 BC118961 7.5
Nek2 BC010302 7.3 Dsg2 AB072269 7.5
Anxa2 BC003327 7.1 Bhlhb2 BC010720 7.3
Cdk6 AF132483 7.0 Cadm2 NM_178721 6.9
Pcdh18 BC052198 6.9 Hopx AF492703 6.6
Uhrf1 AF274046 6.8 Cish BC022178 6.5
Lama4 U59865 6.7 Zbtb20 BC056446 6.5
Myb M12848 6.5 Cd9 BC070474 6.3
Dach1 AF129510 6.2 6330514A18Rik BC099679 6.2
Col12a1 U25652 6.1 Lynx1 BC037541 6.1
Gypa BC148192 6.1 Cacnb4 BC026479 6.0
Jarid1d AF127244 5.8 H2-Aa BC031711 5.8
Cd93 AF081789 5.7 Pcolce AB008548 5.8
Nkd1 AF343352 5.6 Plp1 M15442 5.8
Trim59 BC025430 5.6 Tgfa U65016 5.7
Slc4a1 BC053429 5.5 H2-D1 U47325 5.7
Cadm1 AF434663 5.5 Cltb BC070404 5.6
Emid2 BC075713 5.5 A2m BC072642 5.6
Sept11 BC064466 5.2 S100a1 BC005590 5.4
Plk4 L29479 5.1 Kcnd3 AF107781 5.4
Ezh2 BC079538 5.1 Tlr3 BC099937 5.1
Fkbp10 BC029546 5.1 Nfasc AJ543322 5.1
Ccnb1 BC011478 5.1 Pcolce2 BC051174 5.0
Cited2 BC057126 5.1
Dnajb13 AF419292 5.1
Mfap4 BC022666 5.1
List of protein binding targets that were up-regulated in either the embryo (A) or the adult (B). In total, 479 targets were found for this gene ontology category, with
only those targets with fold change .5.0 shown above. A comprehensive list is presented in Table S8.
doi:10.1371/journal.pone.0033554.t008
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surface–associated epithelial membrane staining was observed
(Fig. 5B). The cytoplasm exhibited an overall fine granular
reactivity, with most immunoreactivity in the basal cytoplasm. A
distinct immunostaining of small vesicles (arrows in Fig. 5B) was
still present. Small segments of the plexus showed a stronger
reactivity (framed area in Fig. 5B). There was no reactivity for
GYPA in vascular endothelial cell membranes.
Cellular & subcellular distribution of SPARC. Cellular
distribution of SPARC at the blood–CSF barrier was also
investigated. Results are illustrated in Fig. 6. SPARC was
detected in individual choroid plexus epithelial cells of animals
Figure 4. Co-localisation of albumin and total plasma protein with SPARC, Glycophorin A or C. A. Immunoreactivity in the lateral
ventricular choroid plexus of E15 mouse embryo immunostained to detect endogenous albumin. Several epithelial cells of the plexus were deemed
albumin-immunopositive (filled arrows), while all other cells were albumin-immunonegative (unfilled arrowheads). To be included in cell counts, the
reaction product had to be present from basolateral to apical membranes and a cell nucleus had to be visible. B. Summary of cell count data from
E15 and adult mouse lateral ventricular choroid plexus. The number of both total protein- and albumin-immunopositive plexus cells increased with
age. As a percentage (numbers in bars), there was a decrease between E15 and adult, with E15 having the higher percentage of protein-positive cells
of any age of the developing mouse. C. Quantitative PCR validation of microarray experiments showed that Sparc, along with Gypa and Gypc were
up-regulated from about 20- to 30-fold in the embryo compared to the adult. D. Western blots of SPARC and GYPA in lateral ventricular choroid
plexus and kidney (used as control) of E15 and adult mice. The level of SPARC did not change in kidney at the two ages: there was a substantial
decrease in adult lateral ventricular choroid plexus compared to E15. A single dark staining band at the correct molecular weight (,35 kDa, mouse
SPARC MW 32 kDa) confirms specificity of the antibody. Levels of GYPA appeared to be higher in the adult kidney compared to E15. The highest level
in the choroid plexus was in the embryo. A dark staining band at ,40 kDa (mouse GYPA MW 43 kDa) confirms cross-reactivity of antibody. E. Single-
cell PCR was performed on cells immunostained for either total protein or albumin. The percentage of immunopositive plexus cells that also
displayed positive gene expression increased with age for both glycophorins, however it decreased for Sparc. Abbreviations: E, embryonic day; Gypa/
GYPA, Glycophorin A; GYPC, Glycophorin C; LV CP, lateral ventricular choroid plexus; MW molecular weight (kDa).
doi:10.1371/journal.pone.0033554.g004
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E16 embryos (Cf. Fig. 6A and B). As found for GYPA, most
immunoreactivity for SPARC was observed in the apical
cytoplasm in the most mature choroid plexus epithelial cells of
the developing choroid plexus opposite the hippocampal anlage
(Fig. 6B). Positive immunoreactivity was visible in E13 plexus
epithelial cells (not shown), and following the peak at E15–16 there
was a decrease in the strength of immunostaining by P2 (not
shown) and adult (Fig. 6C).
At the subcellular level a positive fine granular staining was
visible in small subsets of E14 choroid plexus epithelial cells
throughout the cytoplasm with spared nuclei (Fig. 6A). Larger
dense granules were also present. The perivascular space and
endothelial cells of the choroid plexus showed no reactivity for
SPARC. At E16 a more pronounced SPARC immunoreactivity
was present in the most apical and central part of the part of
Figure 5. Cellular and subcellular distribution of GYPA
immunoreactivity in E15 and adult choroid plexus. A. Embryonic
day 15 (E15) lateral ventricular choroid plexus. The more medial
younger segment of the plexus emerging from the hem and
hippocampal anlage is shown in the lower and right side of the figure.
This part of the plexus shows only weak immunopositive staining for
GYPA (filled arrowheads). At the tip of the plexus most epithelial cells
exhibit a strong granular immunoreactivity in the apical cytoplasm
(arrows) and an apical membrane-associated surface immunostaining
(open arrowheads). Basolateral cell membranes (BM) are also immuno-
positive, as are vascular endothelial cells, which show a marked
immunoreactivity (open arrows), in particular in areas with basolateral
and apical epithelial membrane-associated immunostaining. Strong
membrane immunostaining of erythrocytes (e) is also evident. B. Adult
lateral ventricular choroid plexus. A very weak fine granular cytoplasmic
immunoreactivity is seen in almost all choroid plexus epithelial cells in
contrast to a stronger immunoreactivity found in few small segments of
the plexus (framed area). Note the apparent lack of cytoplasmic
immunostaining in the apical-most part of most epithelial cells (filled
arrowheads), but a distinct immunostaining of small vesicles within the
cytoplasm (arrows). Very few cells exhibit an apical membrane-
associated immunoreactivity (open arrowheads). There was no immu-
noreactivity for GYPA in vascular endothelial cell membranes (open
arrows). Scale bar: 10 mm in all.
doi:10.1371/journal.pone.0033554.g005
Figure 6. Cellular and subcellular distribution of SPARC
immunoreactivity in E14, E16 and adult choroid plexus. A.
Embryonic day 14 (E14) lateral ventricular choroid plexus. The most
lateral (older) segment of the plexus close to the tip is shown in the
upper part of the figure. In this area small subsets of SPARC-
immunopositive epithelial cells exhibit a fine granular immunoreactivity
(open arrowheads) and a few strongly immunostained large ‘vacuoles’
(arrows) in contrast to neighboring epithelial cells without immunore-
activity (closed arrowheads). Note the absence of SPARC-immunostain-
ing in perivascular spaces and in endothelial cell membranes (open
arrow). B. E16 lateral ventricular choroid plexus. A segment of the
plexus similar to that shown in A exhibits many strongly immunoreact-
ing choroid plexus epithelial cells (open arrowheads). The patchy
reaction product in these cells is associated with a tubulocisternal
endoplasmic reticulum (TER). Note the immunostaining along the
basolateral cell membranes (BM) in the strongly SPARC-immunopositive
cells. A few large granules (arrows) are present in the majority of the
epithelial cells including those showing low SPARC-immunoreactivity
(filled arrowheads). SPARC-immunostaining is absent from perivascular
spaces and endothelial cell membranes (open arrow). C. Adult lateral
ventricular choroid plexus. Note the apparent lack of cytoplasmic
immunoreactivity in the apical-most part of the epithelial cells, but the
pronounced immunostaining of large ‘vacuoles’ (arrows) which
represent a combination of multivescicular bodies and lysosomes.
There was no immunoreactivity for SPARC either in perivascular spaces
or in individual endothelial cell membranes. Scale bar: 10 mm in all.
doi:10.1371/journal.pone.0033554.g006
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(Fig. 6B). The immunostaining reaction outlined the tubulocis-
ternal system and extended along the lateral cell membrane to the
basal membrane, which was also stained (Fig. 6B). There was no
SPARC reactivity in endothelial cells forming the stromal centre of
the plexus. In the adult there was an apparent lack of fine granular
cytoplasmic reactivity in the apical-most part of the epithelial cells
combined with an absence of tubulocisternal-associated cytoplas-
mic reactivity (Fig. 6C). However, the basal cytoplasm of most
cells showed a strong staining reaction of large ‘vacuoles’,
multivescicular bodies and lysosomes. There was no reactivity
for SPARC either in perivascular spaces or in individual
endothelial cell membranes.
Vesicle-associated membrane proteins
The vesicle-associated membrane proteins (VAMP1, VAMP5
and VAMP8) are members of a family of SNARE proteins (soluble
NSF attachment protein receptors), mostly involved in vesicle
fusion [72–74]. There are seven members of this protein family in
total: VAMP1/synaptobrevin, VAMP2, VAMP3/cellubrevin,
VAMP4, VAMP5, VAMP7/Ti-vamp, and VAMP8/endobrevin
[75–79]. These proteins are generally distributed in various post-
Golgi structures, as well as on the plasma membrane of
transporting cells. The intracellular traffic between different
membrane compartments and across transporting cells involves
a diverse range of membrane-enclosed intermediates, generated at
plasma membranes via the action of several membrane proteins
(such as the VAMP family) as well as cytosolic coat proteins [80–
82].
Three Vamp targets were enriched in the adult lateral ventricular
choroid plexus: Vamp1 (2.3-fold), Vamp5 (2.2-fold) and Vamp8 (2.2-
fold). The presence of the vesicle-associated membrane proteins in
the epithelial cells of the lateral ventricular choroid plexus and
their up-regulation in the adult supports the idea that there are two
transfer mechanisms operating at the blood–CSF barrier: one
specific for individual proteins; and another transfer mechanism,
which is non-specific, occurring via vesicular uptake and release
[18]. We confirmed GeneChip data using PCR (see Fig. 3C); and
report enrichment of Vamp1, 5 and 8 in the adult mouse lateral
ventricular choroid plexus. The expression of Vamps in plexus
epithelial cells indicate that they may be involved in translocation
of albumin and other plasma proteins across the choroid plexus
epithelium, particularly in the adult. Thus VAMP5 is present on
the outside of both the basolateral and apical membrane of the
cell, helping to package molecules in both the blood and CSF and
inside the cell, while VAMP1 is present on the cell membrane,
working in tandem with Vamp5 [83,84]. The third family member
investigated in the current study, VAMP8 is probably present in
cytoplasmic endosomes of the choroid plexus epithelial cell and is
involved in removing unwanted material from the cell [85,86].
Though these transcripts displayed up-regulated expression in the
adult plexus, they were also present in the embryo. As mentioned
above, many lysosomes were seen in the apical portion of the
plexus epithelial cells that were immunopositive for the albumin-
binding protein SPARC. It is possible that the SPARC-mediated
recruitment of albumin into the epithelial cells of the choroid
plexus on the basolateral (blood) surface is coupled with the
VAMP-mediated uptake of albumin, into vesicles with exocytosis
of albumin on the apical (CSF) surface into the CSF via an
Figure 7. Proposed transepithelial pathway for albumin
through choroid plexus epithelial cells. A. Whole choroid plexus
showing single layer of epithelial cells sitting on thick basement
membrane (see also Fig. 1C). B. Illustration depicting the suggested
routes of albumin from plasma into CSF across the choroid plexus
epithelium. GYPA/C in the endothelial cells may deliver albumin to the
basement membrane (1) from where it can be taken up into the plexus
epithelium by GYPA/C or SPARC (2). From here albumin may travel
along a SPARC-specific pathway through the tubulocisternal endoplas-
mic reticulum (3, and see C) and Golgi (4a), or via a VAMP-mediated
pathway in vacuoles, lysosomes or multivesicular bodies (4b, and see
panel C). On the apical surface of the plexus epithelium, GYPA/C may be
involved in efflux of protein from the cell into the CSF of the ventricles
(5), as validated by extensive GYPA immunoreactivity in embryonic
plexus (Fig. 5A). In the adult, the lack of immunoreactivity in the
endoplasmic reticulum and Golgi (see Fig. 5 and Fig. 6) along with
increased expression of gene products for VAMP molecules (see
Fig. 3C) suggest that the majority of transport possibly occurs via
VAMP-mediated vesicular/lysosomal transport such as shown in (4b). C.
Transmission electron micrograph of ultracryosection from E60 fetal
sheep choroid plexus [87]. Immunolabelled human albumin 6 nm
particles and sheep albumin 12 nm gold particles are shown to co-
localise within the tubulocisternal endoplasmic reticulum. Abbrevia-
tions: CPEC, choroid plexus epithelial cell; CSF, cerebrospinal fluid;
GYPA, glycophorin A; GYPC, glycophorin C; MVB, multivescicular body;
TER, tubulocisternal endoplasmic reticulum. Scale bar: 0.2 mmi nC .
doi:10.1371/journal.pone.0033554.g007
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epithelial cells (4b in Figure 7).
Proposed mechanism for plasma protein transport across
choroid plexus epithelial cells
The present results provide additional evidence for a protein-
specific transfer mechanism that contributes to regulation of the
internal environment of the developing brain. Previous evidence
suggested that this mechanism is particularly important in early
development [16–18,20,21]. This is supported by the present
finding that putative albumin receptors, SPARC, GYPA and
GYPC are up-regulated in the embryonic choroid plexuses of
mice, whereas expression of several members of the VAMP family
of proteins is higher in the adult. These findings support the
previous suggestion that two protein transfer mechanisms operate
in parallel at the level of the choroid plexus epithelial cells of the
blood-CSF barrier: one specific for individual plasma proteins in
the blood to CSF direction, operating predominantly during early
development; and a second, non-specific vesicular uptake
mechanism in both blood to CSF and CSF to blood directions,
operating both during early development and in the adult. The
specificity of the protein specific transfer mechanism appears to be
due to the presence of protein receptors on the basolateral surface
of the choroid plexus epithelial cells. However, a direct link
between these putative albumin transporters and albumin itself still
needs to be established. These studies are in progress.
Some of the differences in subcellular distribution of SPARC
and GYPA demonstrated by immunocytochemistry suggest that
they may play different but complementary roles in albumin
recognition and transport from blood to CSF in epithelial cells of
the developing choroid plexus. A proposed mechanism for this
transfer is illustrated in Fig. 7. Thus GYPA in the endothelial cells
of vessels in the choroid plexus stroma may deliver albumin to the
interstitial space from where it is taken up into the epithelial cell
via the GYPA on the basolateral surface of the plexus cells.
Immunoreactivity for SPARC in the tubulocisternal endoplasmic
reticulum pathway (refer to Fig. 6B; [87,88]; see also Fig. 7C)
early in embryogenesis suggests the involvement of SPARC in
transcellular transport of albumin [86]. SPARC-immunopositivity
of the Golgi apparatus confirms that this glycoprotein is
synthesised by the plexus epithelial cells as also shown by the
positive single cell PCR and immunocytochemistry results. In
contrast, in the adult there was a lack of fine granular cytoplasmic
reactivity in the apical-most part of the epithelial cells combined
with an absence of tubulocisternal-associated cytoplasmic reactiv-
ity (Fig. 6C). However, the basal cytoplasm of most cells showed a
strong staining reaction of large ‘vacuoles’, multivescicular bodies
and lysosomes, perhaps correlating with the up-regulated VAMPs
1, 5 and 8. A summary of the steps in this proposed pathway is
provided in Fig. 7.
Conclusions
In this study we provide a searchable resource for the
elucidation of gene expression at the blood-CSF barrier in the
embryonic mouse compared to the adult. This is the first gene
profiling dataset available for the study of choroid plexus epithelial
cells during development and we have reported a comprehensive
list of transcripts enriched in the blood-CSF barrier of both the
embryo and the adult. These targets encode those involved in
metabolic activities, junction formation, influx and efflux trans-
porters, protein binding and receptors.
One outcome is that it is now possible to make some
comparisons between expression of specific genes in the embryonic
choroid plexus and published functional data for transporters,
tight junction permeability, protein binding and receptors. The
findings also help to explain number of important previous
findings. For example it was reported many years ago that
glutamate is toxic to the brain if administered in the neonatal
period [89]. Some attributed this to ‘‘immaturity’’ of the blood-
brain barrier [90]. However, it can now be seen that the barrier
contribution to toxicity is much more likely to be due to greater
transport by e.g. Slc1a4 (Table 6). Another example is the recent
report of serotonin synthesis by the placenta that appears to be
important for forebrain development [91]. Numerous serotonin
receptors (HTR1-7) were found to be expressed in embryonic
choroid plexus (Table S3) suggesting this as the site of entry of
serotonin into the developing forebrain. The finding of several
albumin binding proteins in the route between blood and CSF
across choroid plexus epithelial cells reinforces earlier evidence for
a specific protein transport mechanism in the developing choroid
plexus. Thus the mechanisms responsible for the nature and
control of the internal environment of the developing brain, supply
of nutrients and exclusion of toxins appear to be well established in
the embryonic choroid plexus
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